Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus.

Thus far, there has been a paucity of studies that have assessed the value of the different gastroesophageal reflux disease (GERD) symptom characteristics in identifying patients with long-segment Barrett's esophagus versus those with short-segment Barrett's esophagus. To determine if any of the symptom characteristics of GERD correlates with long-segment Barrett's esophagus versus short-segment Barrett's esophagus. Patients seen in our Barrett's clinic were prospectively approached and recruited into the study. All patients underwent an endoscopy, validated GERD symptoms questionnaire and a personal interview. Of the 88 Barrett's esophagus patients enrolled into the study, 47 had short-segment Barrett's esophagus and 41 long-segment Barrett's esophagus. Patients with short-segment Barrett's esophagus reported significantly more daily heartburn symptoms (84.1%) than patients with long-segment Barrett's esophagus (63.2%, P = 0.02). There was a significant difference in reports of severe to very severe dysphagia in patients with long-segment Barrett's esophagus versus those with short-segment Barrett's esophagus (76.9%vs. 38.1%, P = 0.02). Longer duration in years of chest pain was the only symptom characteristic of gastroesophageal reflux disease associated with longer lengths of Barrett's mucosa. Reports of severe or very severe dysphagia were more common in long-segment Barrett's esophagus patients. Only longer duration of chest pain was correlated with longer lengths of Barrett's esophagus.

[1]  H. Garewal,et al.  A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. , 2003, Gastrointestinal endoscopy.

[2]  D. Faigel,et al.  Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium , 2003, Digestive Diseases and Sciences.

[3]  V. Savarino,et al.  Comparison of the main oesophageal pathophysiological characteristics between short‐ and long‐segment Barrett's oesophagus , 2002, Alimentary pharmacology & therapeutics.

[4]  B. Avidan,et al.  There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential , 2002, Alimentary pharmacology & therapeutics.

[5]  R. Sampliner,et al.  Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. , 2002 .

[6]  A. Csendes,et al.  Clinical, endoscopic, and functional studies in 408 patients with Barrett’s esophagus, compared to 174 cases of intestinal metaplasia of the cardia , 2002 .

[7]  A. Sonnenberg,et al.  Hiatal Hernia and Acid Reflux Frequency Predict Presence and Length of Barrett's Esophagus , 2002, Digestive Diseases and Sciences.

[8]  D. Provenzale,et al.  Clinical and Demographic Predictors of Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Multivariable Analysis in Veterans , 2001, Journal of clinical gastroenterology.

[9]  P. Lavori,et al.  Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. , 2001 .

[10]  R. Sampliner,et al.  Correlation of oesophageal acid exposure with Barrett's oesophagus length , 2001, Gut.

[11]  A. Weston,et al.  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.

[12]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[13]  J. Peters,et al.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. , 1999, The Journal of thoracic and cardiovascular surgery.

[14]  R. Wong,et al.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.

[15]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[16]  R. Wong,et al.  Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus , 1998, American Journal of Gastroenterology.

[17]  M. Helfand,et al.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.

[18]  A. Zinsmeister,et al.  A new questionnaire for gastroesophageal reflux disease. , 1994, Mayo Clinic proceedings.

[19]  R. Mason,et al.  Motility differences between long-segment and short-segment Barrett's esophagus. , 1993, American journal of surgery.

[20]  A. Cameron,et al.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium. , 1992, Gastroenterology.

[21]  J. Hardcastle,et al.  Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. , 1992, Gut.

[22]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[23]  M F Tsai,et al.  Barrett's esophagus in patients with symptomatic reflux esophagitis. , 1989, The American journal of gastroenterology.

[24]  R. Jensen,et al.  Famotidine: effective treatment of Zollinger-Ellison syndrome. , 1987, Journal of clinical gastroenterology.

[25]  C. Winters,et al.  Esophageal acid sensitivity in Barrett's esophagus. , 1987, Journal of clinical gastroenterology.

[26]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[27]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.

[28]  David F. Cruess,et al.  Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease , 1987 .